semaglutide clinical trials weight loss Two-year effects of in adults with overweight or obesity: the STEP 5 trial Live Updates on Semaglutide's Current

For practitioners, this changes the way we think about intervention: Less guesswork More precision Better adherence driven by satiety Stronger, more predictable outcomes Science

Not all peptide combinations work well together

For long-term adherence, and for the emotional and psychological relationship patients have with food, this distinction is enormously significant

Women benefit most when we treat menopause as the metabolic inflection point it isnot just prescribing GLP-1s in isolation, but considering hormone therapy, addressing sleep disruption (which drives cortisol and undermines any weight loss effort), and building strength to counter the lean mass loss these medications can cause

The primary drivers

Clinical data reveals that discontinuing semaglutide often leads to rapid weight rebound within months